Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Clinical Outcomes Management : JCOM|August 31, 2018
Genomic Testing in the Management of Early-Stage Breast CancerSima Ehsani, Kari Braun WisinskiClinical Breast Cancer|June 8, 2022
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment StrategiesJohanna E Poterala, Thomas Havighurst, Kari Braun WisinskiSurgery|February 27, 2026
Collaborative model between breast surgery and genetic counseling reduces wait times and increases pretesting genetic counseling volumeLauren Maynard, Carolyn Donohue, Alexa Cook, et al.Journal of Cosmetic Dermatology|March 16, 2026
A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor-Hair Serum for the Prevention of Chemotherapy-Induced AlopeciaKatherine Mann, Preethika Potluri, Emma E Paul, et al.Endocrinology|May 8, 2024
Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in MiceJulia N Cheng, Jennifer B Frye, Susan A Whitman, et al.The Oncologist|April 28, 2026
Evaluation of Dronabinol to Decrease Opioid Use for Cancer-Induced Bone PainJennifer Segar, Kiah Farr, Mary Junak, et al.The Breast Journal|March 20, 2015
Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancerSima Ehsani, Roberta M Strigel, Erica Pettke, et al.Journal of Diabetes and Metabolic Disorders|June 8, 2022
Precision medicine journey through omics approachMandana Hasanzad, Negar Sarhangi, Sima Ehsani Chimeh, et al.Journal of Diabetes and Metabolic Disorders|June 8, 2022
Genomic medicine on the frontier of precision medicineMandana Hasanzad, Negar Sarhangi, Anoosh Naghavi, et al.Investigational New Drugs|November 10, 2016
Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancerMurtuza Rampurwala, Kari B Wisinski, Mark E Burkard, et al.Pageof 2